Research progress in screening and diagnosis of lung cancer
10.3760/cma.j.cn121382-20220625-00512
- VernacularTitle:肺癌筛查与诊断的研究进展
- Author:
Hui CHEN
1
Author Information
1. 天津医科大学肿瘤医院肺部肿瘤科，国家恶性肿瘤临床医学研究中心，天津市恶性肿瘤临床医学研究中心，天津市"肿瘤防治"重点实验室，天津 300060
- Keywords:
Lung cancer;
Screening;
Diagnosis;
Prognosis
- From:
International Journal of Biomedical Engineering
2022;45(5):442-447
- CountryChina
- Language:Chinese
-
Abstract:
Effective screening and early diagnosis can significantly improve the prognosis of lung cancer and reduce lung cancer mortality. At present, low-dose computed tomography (LDCT) is the most important screening method for lung cancer. At the same time, the benign and malignant evaluation of pulmonary nodules also determines whether patients can detect cancer early and provides the basis for the cancer prognosis. The related autoantibodies of lung cancer have also been gradually used in the screening and early diagnosis of clinical lung cancer. However, all techniques and methods have their limitations, and the optimal combination may be the best choice. In this review, the research status and challenges of screening and early diagnosis of lung cancer were reviewed.
